SEC Form 4 research
| Issuer | Aura Biosciences, Inc. |
|---|---|
| Tickers | AURA |
| Reporting owners | 28 |
| Officers and directors | 10 |
| Last public filing | 2026-09-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-09-01 | Kratz Erica | A | 100,885 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Kratz Erica | A | 199,115 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Abu-Absi Susan | A | 134,513 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Abu-Absi Susan | A | 265,487 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Elazzouzi Amy | A | 23,540 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Elazzouzi Amy | A | 46,460 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Hopkins Janet Jill | A | 58,850 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Hopkins Janet Jill | A | 116,150 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Person Julie | A | 107,611 | $0 | Not reported |
| 2026-09-01 | 2026-09-01 | Person Julie | A | 212,389 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.